Silo Pharma Inc Cash Flow-to-Debt Ratio
Silo Pharma Inc cash flow-to-debt ratio. Silo Pharma Inc (SILO) has a Cash Flow-to-Debt Ratio of -0.73x as of June 2026, meaning its operating cash flow of $-781.86K could theoretically repay -1% of its total liabilities ($1.07 Million) in one year. Check Silo Pharma Inc (SILO) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Silo Pharma Inc (2011–2025)
Cash flow-to-debt ratio of Silo Pharma Inc from 2011 to 2025. Historical debt coverage capacity for Silo Pharma Inc across 15 annual periods. Check Silo Pharma Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Silo Pharma Inc Cash Flow-to-Debt Ratio by Year (2011–2025)
Silo Pharma Inc cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Silo Pharma Inc. For the full cash flow conversion analysis, see Silo Pharma Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.59x | $-4.66 Million | $1.30 Million | ▼ -122.4% |
| 2024 | -1.61x | $-3.83 Million | $2.38 Million | ▲ +21.5% |
| 2023 | -2.05x | $-3.22 Million | $1.57 Million | ▲ +23.5% |
| 2022 | -2.69x | $-3.50 Million | $1.30 Million | ▼ -68.4% |
| 2021 | -1.60x | $-2.28 Million | $1.43 Million | ▲ +79.9% |
| 2020 | -7.93x | $-1.16 Million | $145.97K | ▼ -415.6% |
| 2019 | -1.54x | $-794.32K | $516.74K | ▼ -352.6% |
| 2018 | 0.61x | $272.64K | $447.98K | ▲ +193.7% |
| 2017 | -0.65x | $-284.62K | $438.34K | ▼ -104.9% |
| 2016 | -0.32x | $-143.56K | $453.10K | ▲ +84.7% |
| 2015 | -2.07x | $-1.02 Million | $490.76K | ▲ +21.5% |
| 2014 | -2.64x | $-1.06 Million | $402.56K | ▼ -508.8% |
| 2013 | -0.43x | $-181.61K | $418.72K | ▲ +16.2% |
| 2012 | -0.52x | $-21.47K | $41.47K | ▲ +96.1% |
| 2011 | -13.23x | $-46.30K | $3.50K | — |